Making Money in Medtech: An Interview with Antoine Papiernik

article image
ARTICLE SUMMARY:

Arguably Europe’s most successful medtech investor, Antoine Papiernik is also something of a contrarian, arguing the best time to invest in medical devices is when everyone else isn’t.

It wo uld be easy for Antoine Papiernik of Sofinnova Partners to join the growing ranks of venture capitalists running away from medtech. After all, Sofinnova has a biotech portfolio that in today’s heady climate has generated returns far greater than any medtech investment is likely to produce. But Papiernik, who was an early investor in companies like Stentys SA and Medtronic PLC’s CoreValve, rejects the implicit message behind such comparisons – i.e., that medtech isn’t a sector worth investing in anymore.

×



This article is restricted to subscribers only.

Sign in to continue reading.

Questions?

We're here to help! Please contact us at: